The Medicines Monitoring Unit (MEMO) and the Hypertension Research Centre, both based at Ninewells Hospital and Medical School, run high quality research and clinical trials to improve patients care.

Medicines Monitoring Unit (MEMO)

The Medicines Monitoring Unit (MEMO) is a research unit that aims to improve the safe and effective use of medicines in patients. MEMO performs randomised controlled clinical trials and pharmacoepidemiological research covering several different areas of medicine.

Under the leadership of Prof Tom MacDonald, Professor of Clinical Pharmacology and Pharmacoepidemiology, our team of physicians, research nurses, statisticians, programmers and administrative staff liaise closely with general practitioners and specialists to investigate important clinical questions relating to drug safety and efficacy. Our emphasis is on high quality research leading to outcomes that guide patient management.

To get a better understanding of what MEMO wants to achieve check out the videos of Professor Tom MacDonald speaking at The Royal Society of Arts.

Further videos, including study videos can be found on our videos page.

Hypertension Research Centre

The Hypertension Research Centre (HRC) was established in 1998 and is affiliated with the Tayside Regional Cardiovascular Risk Clinic, a European Society of Hypertension accredited Centre of Excellence.

The centre is directed by Professor Tom MacDonald with the support of clinical researchers, trial managers, research nurses, statisticians, IT and administrative staff. The aim of the centre is to organise and carry out large-scale clinical trials in hypertensive patients in primary and secondary care. 

The particular areas of interest in hypertension research are the:

  • consequences of high blood pressure on heart structure and function,
  • the renin-angiotensin-aldosterone system in the control of blood pressure and
  • the role of exercise in the assessment of blood pressure control.

We believe every patient, regardless of age or background and wherever they live, deserves access to the best possible evidence-based care.

Evidence gathered from our studies, identify and provide a clear understanding of the mechanisms which give rise to hypertension and cardiovascular disease. This is of considerable importance if we are to target treatment for patients more effectively and allow the development of newer treatment strategies.